Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders.
暂无分享,去创建一个
Tao Wang | John Horan | Machteld Oudshoorn | Haydar Frangoul | Stephanie J. Lee | S. Spellman | Tao Wang | C. Hurley | H. Frangoul | Vikas Gupta | M. Oudshoorn | M. Eapen | Mary Eapen | Stephanie J Lee | M. Haagenson | Stephen R Spellman | Carolyn K Hurley | Michael Haagenson | G. Hale | P. Shaw | Vijay Reddy | Vikas Gupta | J. Horan | Ann Woolfrey | Gregory A Hale | Jason Dehn | Susana Marino | Peter Shaw | A. Woolfrey | S. Marino | V. Reddy | J. Dehn
[1] P. Kaplan,et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. , 1996, Blood.
[2] B. Sandmaier,et al. Defining the intensity of conditioning regimens: working definitions. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[3] Anajane G. Smith,et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. , 1998, Blood.
[4] O. Ringdén,et al. Recent decrease in acute graft-versus-host disease in children with leukemia receiving unrelated donor bone marrow transplants. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[5] H. Deeg,et al. Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. , 1988, Bone marrow transplantation.
[6] H. V. van Houwelingen,et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. , 1996, The New England journal of medicine.
[7] Effie W Petersdorf,et al. MHC Haplotype Matching for Unrelated Hematopoietic Cell Transplantation , 2007, PLoS medicine.
[8] A. Scaradavou,et al. HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection. , 2009, Blood.
[9] J. Klein,et al. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. , 2007, Blood.
[10] Harriet Noreen,et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. , 2004, Blood.
[11] P. Bruzzi,et al. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). , 2001, Blood.
[12] R. Storb,et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. , 1979, The New England journal of medicine.
[13] A. Shad,et al. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. , 1994, Blood.
[14] J. Klein,et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study , 2007, The Lancet.
[15] B. Kremens,et al. Positive serum crossmatch as predictor for graft failure in HLA-mismatched allogeneic blood stem cell transplantation , 2002, Transplantation.
[16] H. Azuma,et al. The impact of anti-HLA antibodies on unrelated cord blood transplantations. , 2010, Blood.
[17] P. Thall,et al. Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. , 2011, Blood.
[18] S. Ogawa,et al. Impact of highly conserved HLA haplotype on acute graft-versus-host disease. , 2010, Blood.
[19] Y. Kodera,et al. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. , 2002, Blood.
[20] M. Tanimoto,et al. No significant association between HA-1 incompatibility and incidence of acute graft-versus-host disease after HLA-identical sibling bone marrow transplantation in Japanese patients. , 2000, International journal of hematology.
[21] S. Spellman,et al. National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[22] R. Storb,et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. , 2011, Blood.
[23] J. Wagner,et al. Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II–III trial , 2005, The Lancet.
[24] H. Inoko,et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. , 2002, Blood.
[26] J. Klein,et al. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[27] C. Hillyer,et al. HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease , 2009, Pediatric blood & cancer.
[28] J. Wagner,et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. , 2007, Blood.
[29] J. Radich,et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. , 2001, Blood.
[30] B. Storer,et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. , 2001, The New England journal of medicine.
[31] H. Schrezenmeier,et al. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia , 2006, Bone Marrow Transplantation.
[32] C. Carcassi,et al. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. , 2006, Blood.
[33] M. Caligiuri,et al. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[34] Harriet Noreen,et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. , 2007, Blood.
[35] Shunichi Kato,et al. Acceptable HLA-mismatching in unrelated donor bone marrow transplantation for patients with acquired severe aplastic anemia. , 2011, Blood.